Global Blow-fill-seal Equipment Market is segmented By Material Type (Polypropylene, Polyethylene), By Product (Bottles, Ampoules, Vials, Prefilled syringes & injectable), By End-User (Pharmaceuticals, Others), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029
Market Overview
The global blow-fill-seal equipment market is estimated to reach at high CAGR during the forecast period (2022-2029).
In the blow-fill-seal (BFS) technology, manufacturers blow, fill, and fix the plastic holders in a solitary activity inside the framework under aseptic conditions. This guarantees the most extreme insurance for filling without the need for human intercession. With the expanding interest for pollution-free filling and bundling procedures, a significant number of the end-use ventures like food, drink, drug, beautifying agents, and others are, bit by bit, moving to the establishment of BFS innovation for plastic bundling arrangements from the conventional methodology.
As of late, the innovation has been received quickly in the drug bundling industry because of the implicit viability and aseptic benefits with various principles and guidelines executed by the USA Food and Drug Administration that has portrayed the blow fill seal innovation as a high-level aseptic interaction. The climbing utilization of the blow fill seal innovation in the drug area is required to proceed as good business across the globe.
Market Dynamics
Increasing demand from pharmaceuticals and healthcare industries
A developing number of drug producers are utilizing progressed disinfection innovations to limit administrator mediation and the danger of defilement in filling and bundling fluid parenteral medications. Blow-fill-seal (BFS) innovation gives different benefits, remembering adaptability for bundling configuration, low working expense, affirmation of deep level of sterility, restricted space prerequisite, restricted segment stock, and restricted work necessity, making it is a favoured innovation for bundling drugs.
Moreover, progressions in BFS innovation empower bundling of a more extensive assortment of compartments, like vials with embedded tips/covers, curve off and re-closeable vials, multi-portion use bottles, eyewash and contact focal point arrangement bottles, unit portion pre-filled needles and injectable, and electrolyte and sports drinks bottles. The interest in cutting-edge aseptic packagings, like containers, vials, pre-filled needles, and ampoules utilizing the blow-fill-seal (BFS) innovation is expanding in the drug area.
Hence, because of the increment sought after these item types, the market for blow-fill-seal (BFS) innovation is set to develop considerably.
cost-to-benefit ratio a concern to small manufacturers
BFS equipment is capital-escalated; the underlying capital needed to build up a BFS innovation plant is high. Trendsetting innovations and a directed climate are needed to pack items aseptically utilizing BFS innovation. Players with high-speculation capacities are entering the market, as exceptional yields are gotten uniquely in the long haul.
Consequently, little producers are hesitant to contribute as they don't have the capital needed for the high starting speculations. This deters producers from putting resources into this innovation and lessens the upstream interest on the lookout.
Segment Analysis
Based on product, the blow-fill-seal equipment market is categorized into bottles, ampoules, vials and pre-filled syringes and injectables.
According to industrial analysis, the prefilled syringe and injectables have a share of 65% in the worldwide market and are expected to increment further by 400bps of 2021's portion of the overall industry during the conjecture time frame. The development is expected because of the interest in totally aseptic and proficient items. Prefilled syringes are improved keeping up with aseptic condition for treatment and medication admission.
This development is inferable from the expanding interest for aseptic medication conveyance to lessen the effect of ongoing illnesses. Be that as it may, utilization of vials is expected to increment in the not-so-distant future because of antibody bundling in the COVID-19 pandemic circumstance.
Geographical Analysis
Based on the geography, the blow-fill-seal equipment market is segmented into North America, Europe, South America, Asia-Pacific, and Middle East & Africa. The demand for blow-fill-seal equipment in the North American market is expected to remain at the dominant position in sales and value generation due to the increasing volume of trade and e-commerce in countries such as the U.S.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the Blow-fill-seal Equipment market in the region. For instance, In July 2016, Curida and PCI Biotech entered into a manufacturing agreement to cater to the increasing demand for blow-fill-seal packaging technology from the pharmaceutical sector.
Moreover, in May 2017, Weiler Engineering and Noxilizer signed an exclusive supply agreement for the blow-fill-seal market. Noxilizer will provide the NOX FLEX™ Rapid Bio decontamination units for new Weiler Engineering, Inc. ASEP-TECH Blow-Fil-Seal systems with this agreement. This will strengthen the company’s product portfolio
Besides, the Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia, and others. Manufacturers BFS have opportunities to invest in the growing market, such as the Asia-Pacific region.
Competitive Landscape
The blow-fill-seal equipment market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Curida AS, Catalent, Inc., Recipharm, Unither Pharmaceuticals, Pharmapack, Rommelag, Weiler Engineering, Unipharma LLC, GlaxoSmithKline plc, Brevetti Angela S.R.L among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Blow-fill-seal Equipment market globally.
Curida AS
Overview: Curida AS is a European pharmaceutical contract development and manufacturing organization (CDMO) with core competence on Blow-Fill-Seal. The company is headquartered in Norway.
Product Portfolio: Curida AS's core competency is in state-of-the-art manufacturing of sterile liquid pharmaceuticals based on unit-dose Blow-Fill-Seal (BFS) technology, ensuring a high quality, fast and robust process with minimal human intervention
Key Developments:
- In November 2017, Curida AS signed a contingency agreement with The Norwegian Armed forces, intending to get flexible access to goods and services while optimizing the cost of the raw materials.
The global blow-fill-seal equipment market report would provide an access to an approx. 61 market data table, 51 figures and 180 pages.